The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 28, 2007

Filed:

Dec. 04, 2002
Applicants:

Heidi Sahagun-krause, München, DE;

Olivier Thillaye Du Boullay, Schwabhausen, DE;

Valerie Thillaye Du Boullay, Schwabhausen, DE;

Laura Casiraghi, München, DE;

Hans-wolfgang Klafki, München, DE;

Pierfausto Seneci, München, DE;

Tobias Braxmeier, München, DE;

Silvia Müller, München, DE;

Wolfgang Fr{hacek Over (O)}hner, München, DE;

Barbara Monse, Weichs, DE;

Sandra Gordon, München, DE;

Hanno M. Roder, Westport, CT (US);

Inventors:

Heidi Sahagun-Krause, München, DE;

Olivier Thillaye Du Boullay, Schwabhausen, DE;

Valerie Thillaye Du Boullay, Schwabhausen, DE;

Laura Casiraghi, München, DE;

Hans-Wolfgang Klafki, München, DE;

Pierfausto Seneci, München, DE;

Tobias Braxmeier, München, DE;

Silvia Müller, München, DE;

Wolfgang Fr{hacek over (o)}hner, München, DE;

Barbara Monse, Weichs, DE;

Sandra Gordon, München, DE;

Hanno M. Roder, Westport, CT (US);

Assignee:

NAD AG, Munich, DE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4035 (2006.01); A61K 31/5377 (2006.01); A61K 31/4192 (2006.01); A61K 31/407 (2006.01); C07D 249/04 (2006.01); C07D 413/14 (2006.01); C07D 487/14 (2006.01); C09B 5/26 (2006.01);
U.S. Cl.
CPC ...
Abstract

This invention relates to N-carbacycle monosubstituted indolocarbazole compounds. Furthermore, this invention relates to medicaments comprising N-carbacycle monosubstituted indolocarbazoles compounds and the use of such compounds for treating non-insulin dependent diabetes mellitus, acute stroke and other neurotraumatic injuries, for treating diabetes mellitus, as a chemotherapeutic for the treatment of various malignant diseases, for treating diseases caused by malfunctioning of specific signaling pathways, and for treating neurodegenerative diseases such as for example Alzheimer's disease.


Find Patent Forward Citations

Loading…